Patents Assigned to SUNSHO PHARMACEUTICAL CO., LTD.
-
Publication number: 20240382434Abstract: Provided are a novel composition and others. The composition at least comprises caryophyllene, and menthol and/or a fat or oil.Type: ApplicationFiled: September 13, 2022Publication date: November 21, 2024Applicant: SUNSHO PHARMACEUTICAL CO., LTD.Inventors: Nobuhiro ZAIMA, Shinichi MATSUMURA, Kohei IWAMOTO, Yuri YOSHIOKA, Kazuya YAMADA, Yamato TSUNODA, Kohei TOYOTA, Masakazu ITO, Tomoya SUZUKI
-
Publication number: 20240016749Abstract: Provided is a novel soft capsule. The soft capsule has a shell comprising gellan gum, wherein the soft capsule satisfies the following requirements: (A) the soft capsule has a disintegration time of 60 minutes or less as measured by a disintegration test method specified in the Japanese Pharmacopoeia using water as a test medium; and/or (B) the soft capsule has a ratio of a crush strength (g) to an outer diameter. (mm) (crush strength/outer diameter ratio) of 210 or more.Type: ApplicationFiled: September 25, 2020Publication date: January 18, 2024Applicant: SUNSHO PHARMACEUTICAL CO., LTD.Inventors: Kohei TOYOTA, Kenichi KOYAMA
-
Publication number: 20230200435Abstract: Provided are a novel agent or composition and others. The agent or composition comprises caryophyllene and is used for at least one selected from the following (purposes) (1) to (3) : (1) promoting relaxation, prolonging a resting-state time, and/or prolonging a motionless time, (2) promoting sleep, and (3) preventing blood pressure elevation. The present invention also relates to a method for inhaling ?-caryophyllene simultaneously with smoking a tobacco product, characterized in that the tobacco product contains a ?-caryophyllene-containing seamless capsule in a tobacco filter, wherein the seamless capsule contains an essential oil containing ?-caryophyllene as an active ingredient. The applicants found that pulmonary inhalation of ?-caryophyllene by the above method allows ?-caryophyllene to be efficiently distributed throughout the body, leading to achievements of relaxing and sleep-inducing effects, etc.Type: ApplicationFiled: March 10, 2021Publication date: June 29, 2023Applicants: KINKI UNIVERSITY, INABATA KORYO CO., LTD., SUNSHO PHARMACEUTICAL CO., LTD.Inventors: Nobuhiro ZAIMA, Yuri YOSHIOKA, Shinichi MATSUMURA, Kohei IWAMOTO, Kazuya YAMADA, Takanori KOBAYASHI
-
Publication number: 20230133580Abstract: An object of the present invention is to provide is a novel composition and others. The composition comprises l-menthol and at least one ingredient (X) selected from dicarboxylic acid esters, diol esters, monocarboxylic acid esters, esters of polyols having three or more hydroxy groups, esters of polycarboxylic acids having three or more carboxyl groups, polyol ethers, polyamines, and alcohols having six or more carbon atoms.Type: ApplicationFiled: March 30, 2021Publication date: May 4, 2023Applicant: SUNSHO PHARMACEUTICAL CO., LTD.Inventors: Kazuya YAMADA, Tomoya SUZUKI, Masakazu ITO, Kouichi DOBASHI
-
Publication number: 20210177870Abstract: This is to provide a useful application of plasmalogen, which is not yet known. A composition contains plasmalogen for enhancing a verbal memorization ability and/or a visual memorization ability.Type: ApplicationFiled: August 23, 2019Publication date: June 17, 2021Applicants: NIHON PHARMACEUTICAL CO., LTD., SUNSHO PHARMACEUTICAL CO., LTD.Inventors: Tatsuya WADA, Yoshiharu MATAHIRA, Hirofumi WATANABE, Masaki OOKAWARA
-
Publication number: 20210161820Abstract: Provided is a granulation composition that comprises core grains, coating grains and a binder for binding the core grains to each other and also binding the core grains to the coating grains to thereby maintain a granular shape, characterized in that: the coating grains adhere around a main granulation body comprising the core grains and the binder; the coating grains are insoluble in the binder; the core grains and/or the binder contain a medicinal ingredient or a biofunctional ingredient; and the developed interfacial area ratio Sdr is 100-700. According to this granulation composition, a uniform granulated product which is surface-coated with the coating grains and hardly segregated can be stably obtained, even if using a dilute solution with low gel strength as the binder. By setting the gelling agent concentration in the binder at a low level to give a dilute solution, therefore, the granulation composition having excellent properties can be produced at a high productivity.Type: ApplicationFiled: April 4, 2019Publication date: June 3, 2021Applicant: SUNSHO PHARMACEUTICAL CO., LTD.Inventors: Shunsuke SEI, Misuzu MINEDA, Chikara MORIZANE, Wataru HIRASAWA
-
Patent number: 10493036Abstract: A capsule excellent in enteric property with the assumption that gelatin is used as a main base material of the capsule coating. An alkali-treated gelatin and carrageenan are contained as base materials of the capsule coating. In the gastric (aqueous) environment, the alkali-treated gelatin which is positively (+) charged coexists with the carrageenan which is negatively (?) charged, and amino groups (NH4+) in the gelatin react with sulfate groups (SO3?) in the carrageenan so that the capsule coating is insolubilized. On the other hand, in the intestinal (aqueous) environment, the alkali-treated gelatin which is negatively (?) charged coexists with the carrageenan which is negatively (?) charged, and the amino groups (NH4+) in the gelatin are repulsive to the sulfate groups (SO3?) in the carrageenan so that the capsule coating quickly disintegrates and dissolves.Type: GrantFiled: August 10, 2016Date of Patent: December 3, 2019Assignee: SUNSHO PHARMACEUTICAL CO. LTDInventors: Takayuki Fukasawa, Kenichi Koyama, Tomoya Suzuki
-
Publication number: 20180221288Abstract: A capsule excellent in enteric property with the assumption that gelatin is used as a main base material of the capsule coating. An alkali-treated gelatin and carrageenan are contained as base materials of the capsule coating. In the gastric (aqueous) environment, the alkali-treated gelatin which is positively (+) charged coexists with the carrageenan which is negatively (?) charged, and amino groups (NH4+) in the gelatin react with sulfate groups (SO3?) in the carrageenan so that the capsule coating is insolubilized. On the other hand, in the intestinal (aqueous) environment, the alkali-treated gelatin which is negatively (?) charged coexists with the carrageenan which is negatively (?) charged, and the amino groups (NH4+) in the gelatin are repulsive to the sulfate groups (SO3?) in the carrageenan so that the capsule coating quickly disintegrates and dissolves.Type: ApplicationFiled: August 10, 2016Publication date: August 9, 2018Applicant: SUNSHO PHARMACEUTICAL CO. LTDInventors: Takayuki FUKASAWA, Kenichi KOYAMA, Tomoya SUZUKI
-
Patent number: 10015984Abstract: The purpose of the present invention is to provide a breakable capsule, which is characterized by having no adhesion between capsules each other, having no over time change of the capsule contents, having excellent heat resistance and moisture resistance, being easily ruptured under the pressure imposed by the fingers, having good cracking feeling, and releasing the content and the present invention relates to a breakable capsule, which comprises a capsule having a content and a capsule shell, wherein the capsule is characterized by having an oily ingredient as a content, having at least a shell-forming material as a capsule shell, and satisfying the following equations (1) and (2), 150<(X)<630??(1) wherein (X) represents crush strength (g)/outer diameter of a capsule (mm), 0.15?(Y)?0.Type: GrantFiled: April 15, 2014Date of Patent: July 10, 2018Assignee: SUNSHO PHARMACEUTICAL CO., LTD.Inventor: Takashi Kondo
-
Publication number: 20160021927Abstract: The purpose of the present invention is to provide a breakable capsule, which is characterized by having no adhesion between capsules each other, having no over time change of the capsule contents, having excellent heat resistance and moisture resistance, being easily ruptured under the pressure imposed by the fingers, having good cracking feeling, and releasing the content and the present invention relates to a breakable capsule, which comprises a capsule having a content and a capsule shell, wherein the capsule is characterized by having an oily ingredient as a content, having at least a shell-forming material as a capsule shell, and satisfying the following equations (1) and (2), 150<(X)<630 ??(1) wherein (X) represents crush strength (g)/outer diameter of a capsule (mm), 0.15?(Y)?0.Type: ApplicationFiled: April 15, 2014Publication date: January 28, 2016Applicant: SUNSHO PHARMACEUTICAL CO., LTD.Inventor: Takashi KONDO